LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-17
Case ID: NM_000314.8_c.975del_20261117_161904
Framework: ACMG/AMP 2015
Variant classification summary

NM_000314.8:c.975del

PTEN  · NP_000305.3:p.(Asp326ThrfsTer18)  · NM_000314.8
GRCh37: chr10:89720822 CT>C  ·  GRCh38: chr10:87961065 CT>C
Gene: PTEN Transcript: NM_000314.8
Final call
Likely Pathogenic
PVS1 very strong PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Asp326ThrfsTer18)
gnomAD AF
ClinVar
Uncertain significance
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PVS1 Very Strong: exon 8 frameshift p.D326 is 5' of the PTEN NMD threshold.
2
PM2 Supporting: the variant is absent from gnomAD v2.1 and v4.1.
Final determination: Under Rule20 of the ClinGen PTEN Expert Panel Version 3.2 framework, one Pathogenic Very Strong criterion plus one Pathogenic Supporting criterion yields Likely Pathogenic.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Met Met, very strong: exon 8 frameshift p.D326 is 49 amino-acid positions 5' of the p.D375 NMD threshold in NM_000314.8.
cspec vcep_pvs1_decisiontree_pten pvs1_variant_assessment
PS1 N/A Not applicable: NM_000314.8:c.975del is a frameshift, p.(Asp326ThrfsTer18), rather than the missense or splicing change required by the PTEN PS1 rule.
cspec
PS2 Not assessed Not assessed: no documented proband, parental maternity/paternity confirmation, family-history status, or proven/assumed de novo observation is available.
cspec
PS3 Not assessed Not assessed: mmc2 Table S2 has no c.975del or p.D326Tfs*18 functional-assay row meeting the VCEP's required High_conf and Cum_score evidence.
cspec vcep_mmc2 PMID:29706350
PS4 Not assessed Not assessed: no variant-specific affected-versus-control counts, frequency comparison, odds ratio, confidence interval, or PTEN VCEP specificity score is available.
cspec PMID:35924163
PM1 Not met Not met: Residue 326 is outside the PTEN PM1 catalytic motifs 90–94, 123–130, and 166–168, and the VCEP names no usable somatic-hotspot source or route.
cspec hotspots
PM2 Met Met at supporting strength: the variant is absent from gnomAD v2.1 and v4.1, below the VCEP PM2 threshold of <0.00001 (0.001%).
cspec gnomad_v2 gnomad_v4
PM3 N/A Not applicable: the PTEN VCEP explicitly excludes PM3 for PTEN.
cspec
PM4 N/A Not applicable: c.975del is a frameshift, while the PTEN PM4 rule names only in-frame length changes and stop-loss variants.
cspec pvs1_variant_assessment
PM5 N/A Not applicable: The variant is a frameshift, whereas PTEN PM5 requires a missense change at a residue with a previously observed pathogenic or likely pathogenic missense change.
cspec pm5_candidates
PM6 Not assessed Not assessed: no assumed de novo observation with disease status, family-history status, and parental maternity/paternity information is documented.
cspec
PP1 Not assessed Not assessed: no affected relatives, segregation results, or countable meioses are documented for this variant.
cspec
PP2 N/A Not applicable: NM_000314.8:c.975del is a frameshift, not the missense variant required by the PTEN PP2 rule.
cspec
PP3 N/A Not applicable: c.975del is a coding frameshift, while the PTEN PP3 rule covers only splicing and missense variants.
cspec
PP4 N/A Not applicable: the ClinGen PTEN VCEP explicitly marks PP4 as Not Applicable.
cspec
PP5 N/A Not applicable: the ClinGen PTEN VCEP explicitly marks PP5 as Not Applicable.
cspec
BA1 Not met Not met: the variant is absent from gnomAD v2.1 and v4.1, below the VCEP BA1 threshold of >0.00056 (0.056%).
cspec gnomad_v2 gnomad_v4
BS1 Not met Not met: the variant is absent from gnomAD v2.1 and v4.1, rather than within the VCEP BS1 range of 0.0000043–0.00056.
cspec gnomad_v2 gnomad_v4
BS2 Not assessed Not assessed: gnomAD reports no variant observations, so no confirmed homozygous healthy or PHTS-unaffected individual can be evaluated.
cspec gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: mmc2 Table S2 has no p.D326Tfs*18 functional result showing high-confidence phosphatase activity >0 for the VCEP's BS3 path.
cspec vcep_mmc2 PMID:29706350
BS4 Not assessed Not assessed: no affected relatives lacking the variant and no family count for lack of segregation are documented.
cspec
BP1 N/A Not applicable: The PTEN VCEP explicitly designates BP1 as Not Applicable.
cspec
BP2 Not assessed Not assessed: no documented trans, cis, or phase-unknown observation with a different pathogenic or likely pathogenic PTEN variant was available.
cspec
BP3 N/A Not applicable: the PTEN VCEP CSPEC entry explicitly designates BP3 as Not Applicable.
cspec
BP4 N/A Not applicable: c.975del is a truncating frameshift, and BP4 does not apply to frameshift variants under the PTEN VCEP rule.
cspec
BP5 Not assessed Not assessed: no highly penetrant alternate molecular diagnosis and no documented personal or family history excluding overlap with PTEN are available.
cspec
BP6 N/A Not applicable: the ClinGen PTEN VCEP explicitly marks BP6 as Not Applicable.
cspec
BP7 N/A Not applicable: c.975del is a coding frameshift, whereas PTEN BP7 is limited to synonymous or intronic variants at or beyond +7/-21.
cspec
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.